Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cody J Peer

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 24, 2014
Quantitative determination of mithramycin in human plasma by a novel, sensitive ultra-HPLC-MS/MS method for clinical pharmacokinetic applicationJeffrey Roth, Cody J Peer, Brigitte Widemann, et al.
BMC Pulmonary Medicine|July 13, 2018
Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumabDante A Suffredini, Jung-Min Lee, Cody J Peer, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2017
Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphismsTristan M Sissung, Cody J Peer, Neha Korde, et al.
Journal of Toxicology and Environmental Health. Part A|December 3, 2009
Subcellular localization of the amide class herbicide 3,4-dichloropropionanilide (DCPA) in T cells and hepatocytesMiranda L Hanson, Cody J Peer, Rodney Brundage, et al.
Cancer Chemotherapy and Pharmacology|January 3, 2020
Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine gliomaLouis T Rodgers, Cynthia M Lester McCully, Arman Odabas, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2019
PBPK modeling-based optimization of site-specific chemo-photodynamic therapy with far-red light-activatable paclitaxel prodrugMengjie Li, Luong Nguyen, Bharathiraja Subramaniyan, et al.
Photochemistry and Photobiology|December 29, 2019
Local and Systemic Antitumor Effects of Photo-activatable Paclitaxel Prodrug on Rat Breast Tumor ModelsBharathiraja Subramaniyan, Pallavi Rajaputra, Luong Nguyen, et al.
Pharmacotherapy|October 20, 2021
Alemtuzumab clearance, lymphocyte count, and T-cell chimerism after hematopoietic stem cell transplant in sickle cell diseaseDana Furstenau, Cody J Peer, Thomas E Hughes, et al.
Neuro-Oncology Advances|April 21, 2020
Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate modelsCynthia Lester McCully, Louis T Rodgers, Rafael Cruz, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2020
Cerebrospinal fluid penetration of the colony-stimulating factor-1 receptor (CSF-1R) inhibitor, pexidartinibPriya S Shankarappa, Cody J Peer, Arman Odabas, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 24, 2014
Quantitative determination of mithramycin in human plasma by a novel, sensitive ultra-HPLC-MS/MS method for clinical pharmacokinetic applicationJeffrey Roth, Cody J Peer, Brigitte Widemann, et al.
BMC Pulmonary Medicine|July 13, 2018
Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumabDante A Suffredini, Jung-Min Lee, Cody J Peer, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2017
Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphismsTristan M Sissung, Cody J Peer, Neha Korde, et al.
Journal of Toxicology and Environmental Health. Part A|December 3, 2009
Subcellular localization of the amide class herbicide 3,4-dichloropropionanilide (DCPA) in T cells and hepatocytesMiranda L Hanson, Cody J Peer, Rodney Brundage, et al.
Cancer Chemotherapy and Pharmacology|January 3, 2020
Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine gliomaLouis T Rodgers, Cynthia M Lester McCully, Arman Odabas, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2019
PBPK modeling-based optimization of site-specific chemo-photodynamic therapy with far-red light-activatable paclitaxel prodrugMengjie Li, Luong Nguyen, Bharathiraja Subramaniyan, et al.
Photochemistry and Photobiology|December 29, 2019
Local and Systemic Antitumor Effects of Photo-activatable Paclitaxel Prodrug on Rat Breast Tumor ModelsBharathiraja Subramaniyan, Pallavi Rajaputra, Luong Nguyen, et al.
Pharmacotherapy|October 20, 2021
Alemtuzumab clearance, lymphocyte count, and T-cell chimerism after hematopoietic stem cell transplant in sickle cell diseaseDana Furstenau, Cody J Peer, Thomas E Hughes, et al.
Neuro-Oncology Advances|April 21, 2020
Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate modelsCynthia Lester McCully, Louis T Rodgers, Rafael Cruz, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2020
Cerebrospinal fluid penetration of the colony-stimulating factor-1 receptor (CSF-1R) inhibitor, pexidartinibPriya S Shankarappa, Cody J Peer, Arman Odabas, et al.
Pageof 14